Altered Neural Circuitry May Contribute To Disturbances In Cognitive Functions In Schizophrenia, Say Pitt Researchers

April 28, 1998

PITTSBURGH, April 28 -- Study results published by University of Pittsburgh researchers in today's Proceedings of the National Academy of Sciences offer a strong biological explanation for why cognitive processes become disordered in patients with schizophrenia.

"These results are important because even though psychosis -- the delusions and hallucinations associated with this disease is its most striking feature, disturbance in cognitive processing is often the most disabling, persistent and difficult to treat feature of schizophrenia," commented David A. Lewis M.D., professor of psychiatry and neuroscience and co-author of the study.

Schizophrenia is a serious and common mental illness that afflicts more than 2 million people in the United States. The onset of the disease usually occurs during late adolescence or early adulthood and frequently leads to a life of disability, and, in 10 to 15 percent of cases, ends in suicide. Families of patients with the illness often bear tremendous emotional and financial burdens related to it.

Dr. Lewis and his colleagues found that a specific component of the neural circuitry, or connections among brain cells, of the prefrontal cortex is substantially altered in a majority of people with the disorder. The affected component is called a chandelier neuron axon cartridge and plays a major role in controlling other neurons that process information within the prefrontal cortex and then send it to other brain regions. The prefrontal cortex is responsible for complex thinking processes, such as making judgments, formulating plans, organizing speech and other forms of communication. Disturbances in these processes severely affect the ability of an individual with schizophrenia to complete their education, gain employment and function in society.

The Pitt scientists examined post-mortem brain specimens from a total of 55 subjects whose families consented to the study. Dr. Lewis and his colleagues discovered that the number of chandelier neuron axon cartridges was reduced on average by 40 percent in subjects with schizophrenia compared to both normal controls and subjects with psychiatric disorders other than schizophrenia. Their study indicates that the alterations in chandelier neuron axon cartridges represent a disturbance in brain biology that may be specific to the disease process of schizophrenia. In addition, the findings do not appear to be a consequence of the treatment with antipsychotic medications.

"We can't determine from this study whether the alterations in chandelier neuron axon cartridges are the primary brain disturbance in schizophrenia, or if they represent the brain's response to some other abnormality," continued Dr. Lewis. "But the results do open options for the development of new treatments targeted at improving the cognitive symptoms of this disorder."

Co-authors of this study are Tsung-Ung Woo, M.D., Ph.D., formerly of Pitt, now a resident in psychiatry at UCLA and Richard E. Whitehead, B.S., research specialist and Darlene S. Melchitzky, M.S., research principal, from the department of psychiatry, University of Pittsburgh School of Medicine.

For additional information about UPMC Health System, please access http://www.upmc.edu.
-end-


University of Pittsburgh Medical Center

Related Schizophrenia Articles from Brightsurf:

Schizophrenia: When the thalamus misleads the ear
Scientists at the University of Geneva (UNIGE) and the Synapsy National Centre of Competence in Research (NCCR) have succeeded in linking the onset of auditory hallucinations - one of the most common symptoms of schizophrenia - with the abnormal development of certain substructures of a region deep in the brain called the thalamus.

Unlocking schizophrenia
New research, led by Prof. LIU Bing and Prof. JIANG Tianzi from the Institute of Automation of the Chinese Academy of Sciences and their collaborators have recently developed a novel imaging marker that may help in the personalized medicine of psychiatric disorders.

Researchers discover second type of schizophrenia
In a study of more than 300 patients from three continents, over one third had brains that looked similar to healthy people.

New clues into the genetic origins of schizophrenia
The first genetic analysis of schizophrenia in an ancestral African population, the South African Xhosa, appears in the Jan.

Dietary supplement may help with schizophrenia
A dietary supplement, sarcosine, may help with schizophrenia as part of a holistic approach complementing antipsychotic medication, according to a UCL researcher.

Schizophrenia: Adolescence is the game-changer
Schizophrenia may be related to the deletion syndrome. However, not everyone who has the syndrome necessarily develops psychotic symptoms.

Study suggests overdiagnosis of schizophrenia
In a small study of patients referred to the Johns Hopkins Early Psychosis Intervention Clinic (EPIC), Johns Hopkins Medicine researchers report that about half the people referred to the clinic with a schizophrenia diagnosis didn't actually have schizophrenia.

The ways of wisdom in schizophrenia
Researchers at UC San Diego School of Medicine report that persons with schizophrenia scored lower on a wisdom assessment than non-psychiatric comparison participants, but that there was considerable variability in levels of wisdom, and those with higher scores displayed fewer psychotic symptoms.

Recognizing the uniqueness of different individuals with schizophrenia
Individuals diagnosed with schizophrenia differ greatly from one another. Researchers from Radboud university medical center, along with colleagues from England and Norway, have demonstrated that very few identical brain differences are shared amongst different patients.

Resynchronizing neurons to erase schizophrenia
Today, a decisive step in understanding schizophrenia has been taken.

Read More: Schizophrenia News and Schizophrenia Current Events
Brightsurf.com is a participant in the Amazon Services LLC Associates Program, an affiliate advertising program designed to provide a means for sites to earn advertising fees by advertising and linking to Amazon.com.